LOUISVILLE, Ky.--(BUSINESS WIRE)--AdaptivEndo™ and Plasmapp are working together to evaluate the use of low-temperature hydrogen peroxide gas plasma for various flexible endoscopy applications. The sterilization system currently being evaluated is the tabletop STERLINK Plus. The initial focus of the evaluation is the AdaptivEndo™ GI endoscope platform, which utilizes a reposable handpiece (hybrid endoscopy)..

肯塔基州路易斯维尔（BUSINESS WIRE）-AdaptivEndo™ 和Plasmapp正在共同评估低温过氧化氢气体等离子体在各种灵活内窥镜检查应用中的应用。目前正在评估的灭菌系统是桌面STERLINK Plus。评估的最初重点是AdaptivEndo™ GI内窥镜平台，利用可重复的手机（混合内窥镜）。。

“With the growth of therapeutic endoluminal procedures, such as endoluminal sleeve gastroplication, the need for sterile endoscopes for the OR has been growing. We had been seeking alternatives to HLD and steam sterilization when we found the Plasmapp solutions at a trade show in Germany last year,” AdaptivEndo™ President, Ed Fancher said.

“随着腔内袖状胃折叠术等治疗性腔内手术的发展，OR对无菌内窥镜的需求不断增长。当我们去年在德国的一个贸易展览上发现Plasmapp解决方案时，我们一直在寻找HLD和蒸汽灭菌的替代品，”AdaptivEndo™ 总统Ed Fancher说。

“The STERLINK Plus provided a small table-top option for sterilization that required only 14 minutes to complete a cycle. This solution provided a greater degree of confidence versus HLD (High-Level Disinfection ) and is the ecological solution as you do not have to use any toxic chemical disinfectants.”.

“STERLINK Plus提供了一个小型桌面选项，只需14分钟即可完成一个循环。该解决方案比HLD（高级消毒）提供了更高的信心，并且是生态解决方案，因为您不必使用任何有毒的化学消毒剂“。

Following the establishment of Plasmapp America, the company wasted no time in introducing its FDA-approved medical products to the market in the first quarter of 2023.“Plasmapp has a long history of developing innovative technologies supporting sterilization and disinfection. With an expansive installation base of equipment throughout Asia, Europe, and the Middle East, we have pivoted our focus to the Americas,” said Marty Trabish, CEO of Plasmapp America.

在PlasmaApp America成立之后，该公司在2023年第一季度没有时间将其FDA批准的医疗产品推向市场。“Plasmapp在开发支持灭菌和消毒的创新技术方面有着悠久的历史。在亚洲，欧洲和中东地区，我们将重点转向美洲，”Marty Trabish说，Plasmapp America首席执行官。

“We have been actively seeking partners in various clinical areas to evaluate opportunities and needs in these verticals. The relationship with AdaptivEndo™ allowed us to explore the potential applications within flexible endoscopy, specifically GI endoscopy.”.

“我们一直在积极寻求各个临床领域的合作伙伴来评估这些眩晕的机会和需求。与AdaptivEndo的关系™ 使我们能够探索灵活内窥镜检查的潜在应用，特别是GI内窥镜检查。”。

Plasmapp stands at the forefront of plasma technology innovation. Born within the laboratories of the Korea Advanced Institute of Science and Technology (KAIST) in 2015, the company has since emerged as a sterilization innovator, providing state-of-the-art solutions in sterilization, biological inactivation, regenerative activation, and other technologies.

Plasmapp处于等离子体技术创新的前沿。该公司于2015年出生于韩国先进科学技术研究院（KAIST）的实验室，自此成为灭菌创新公司，为灭菌，生物灭活，再生活化和其他技术提供最先进的解决方案。

Today, their trusted products are protected by more than 158 patents and certified in more than 26 countries worldwide..

今天，他们的可信产品受到158多项专利的保护，并在全球26个国家获得认证。。

Business inquiries within the United States can be submitted to Marty Trabish, CEO of Plasmapp America, at marty@plasmapp.com. www.plasmapp.com

美国境内的商业调查可以提交给Plasmapp America首席执行官Marty Trabishmarty@plasmapp.com.www.plasmapp.com

AdaptivEndo™ is dedicated to advancing flexible, single-use endoscopes that reduce a patient’s risk and increase access to care. We combine the best aspects of single-use device with the performance of a high-quality, reusable system (hybrid) that will innovate and disrupt endoscopy. Business inquiries can be submitted to Ed Fancher, President of AdaptivEndo™, at hfancher@adaptivendo.com.

AdaptivEndo™ 致力于推进灵活的一次性内窥镜，降低患者的风险并增加护理机会。我们将一次性使用设备的最佳方面与高质量，可重复使用的系统（hybrid）的性能相结合，该系统将创新和破坏内窥镜检查。业务查询可以提交给AdaptivEndo总裁Ed Fancher™, 在hfancher@adaptivendo.com.

www.adaptivendo.com.

www.adaptivendo.com。